Epilepsy with myoclonic absences
ICD-10 G40.4 · ICD-11 8A61.23

Treatment of Epilepsy with Myoclonic Absences in Adults (Age 16 and Older)

This protocol covers the management of epilepsy with myoclonic absences specifically in adult patients aged 16 years and older. The approach follows an evidence-graded framework for this age group.

Clinical scenario: An adult patient (age 16 or older) presenting with epilepsy with myoclonic absences (ICD-10 G40.4 / ICD-11 8A61.23) who requires a structured first-line treatment plan.
Treatment direction: The protocol recommends a trial of a single antiseizure medication drawn from a defined Level D evidence category — monotherapy is to be fully explored before any combination approach is considered. Which agent to select, and the criteria for moving forward, are specified in the full protocol.
Instant Access to Structured Evidence-Based Regimens

References

  • Adults
  • Level D: gabapentin, levetiracetam, vigabatrin
  • Monotherapy with all indicated AEDs should be attempted before initiating combination therapy.
View source ↗